Edition:
United States

Arena Pharmaceuticals Inc (ARNA.O)

ARNA.O on Nasdaq

54.01USD
17 May 2019
Change (% chg)

$-1.81 (-3.24%)
Prev Close
$55.82
Open
$55.18
Day's High
$55.85
Day's Low
$53.89
Volume
833,342
Avg. Vol
487,918
52-wk High
$58.00
52-wk Low
$31.97

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $1,019.33
Shares Outstanding(Mil.): 39.22
Dividend: --
Yield (%): --

Financials

  ARNA.O Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.59 -- --
ROI: -13.16 8.91 13.82
ROE: -39.77 10.05 15.24

Earnings vs. Estimates